Fundación Universidad Católica de Valencia San Vicente Mártir   Report issue

Foundation Phase 2 Phase 3
Founded: Valencia Spain (2003)

Organization Overview

First Clinical Trial
2013
NCT01802255
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

F Javier Belda | Fundación Universidad Católica de Valencia San Vicente Mártir | Universidad Católica de Valencia San Vicente Mártir | Valencian Institute of Neurorehabilitation Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 2)

Fluoride Poisoning (Phase 3)

Motor Neuron Disease (Phase 2)

Multiple Sclerosis (Phase 2)

Poisoning (Phase 3)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 9